Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors
Özet
Carbonic anhydrase (CA) enzymes are involved in many physiological events. These enzymes, which contain Zn2+ in their structure, can be easily inhibited by dithiocarbamate compounds. In addition, CA enzyme inhibitory activities are known in groups such as sulfonamide and methylsulfonyl. For this purpose, in this study, a series of 23 new dithiocarbamate-methylsulfonyl derivatives were synthesized and their CA enzyme inhibitory activities were investigated. The inhibition potentials of the obtained compounds against the human CA I and CA II enzymes were investigated by the in vitro enzyme isolation method. It is seen that the compounds show activity at the nanomolar level. Molecular docking studies of the compounds were carried out by in silico methods. The poses of compounds 2a, 2e, 2o, and 2t are presented. © 2022 Deutsche Pharmazeutische Gesellschaft.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Osmaniye, Derya | |
| dc.contributor.author | Türkeş, Cüneyt | |
| dc.contributor.author | Demir, Yeliz | |
| dc.contributor.author | Özkay, Yusuf | |
| dc.contributor.author | Beydemir, Şükrü | |
| dc.contributor.author | Kaplancıklı, Zafer A. | |
| dc.date.accessioned | 2026-10-18T20:27:39.452030439Z | |
| dc.date.available | 2026-10-18T20:27:39.452030439Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Carbonic anhydrase (CA) enzymes are involved in many physiological events. These enzymes, which contain Zn2+ in their structure, can be easily inhibited by dithiocarbamate compounds. In addition, CA enzyme inhibitory activities are known in groups such as sulfonamide and methylsulfonyl. For this purpose, in this study, a series of 23 new dithiocarbamate-methylsulfonyl derivatives were synthesized and their CA enzyme inhibitory activities were investigated. The inhibition potentials of the obtained compounds against the human CA I and CA II enzymes were investigated by the in vitro enzyme isolation method. It is seen that the compounds show activity at the nanomolar level. Molecular docking studies of the compounds were carried out by in silico methods. The poses of compounds 2a, 2e, 2o, and 2t are presented. © 2022 Deutsche Pharmazeutische Gesellschaft. | |
| dc.description.sponsorship | As the authors of this study, we thank the Anadolu University Faculty of Pharmacy Central Analysis Laboratory for their support and contributions. This study was supported by the Research Fund of Erzincan Binali Yıldırım University (Grant Number TSA‐2020‐729) and the Research Fund of Anadolu University (Grant Number 2102S003). | |
| dc.identifier.doi | 10.1002/ardp.202200132 | |
| dc.identifier.eissn | 1521-4184 | |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.issue | 8 | |
| dc.identifier.pmid | 35502846 | |
| dc.identifier.scopus | 2-s2.0-85129265807 | |
| dc.identifier.startpage | 2200132 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/12786 | |
| dc.identifier.volume | 355 | |
| dc.identifier.wos | WOS:000789857700001 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | Archiv der Pharmazie | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | dithiocarbamate | |
| dc.subject | hCA I | |
| dc.subject | hCA II | |
| dc.subject | methysulfonyl | |
| dc.subject | molecular docking | |
| dc.subject | Carbonic Anhydrase I | |
| dc.subject | Carbonic Anhydrase II | |
| dc.subject | Carbonic Anhydrase Inhibitors | |
| dc.subject | Humans | |
| dc.subject | Molecular Docking Simulation | |
| dc.subject | Molecular Structure | |
| dc.subject | Structure-Activity Relationship | |
| dc.subject | 2 (4 bromophenyl) 2 oxoethyl 4 (methylsulfonyl)piperazine 1 carbodithioate | |
| dc.subject | 2 (4 cyanophenyl) 2 oxoethyl 4 (methylsulfonyl)piperazine 1 carbodithioate | |
| dc.subject | 4 chlorobenzyl 4 (methylsulfonyl)piperazine 1 carbodithioate | |
| dc.subject | benzyl 4 (methylsulfonyl)piperazine 1 carbodithioate | |
| dc.subject | carbonate dehydratase I | |
| dc.subject | carbonate dehydratase II | |
| dc.subject | carbonate dehydratase inhibitor | |
| dc.subject | dithiocarbamic acid | |
| dc.subject | mesylic acid derivative | |
| dc.subject | unclassified drug | |
| dc.subject | Article | |
| dc.subject | biological activity | |
| dc.subject | computer model | |
| dc.subject | controlled study | |
| dc.subject | drug design | |
| dc.subject | drug synthesis | |
| dc.subject | enzyme activity | |
| dc.subject | enzyme inhibition | |
| dc.title | Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 69 | |
| rdl.citation.wos | 63 | |
| rdl.department | Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) | |
| rdl.wos.index | Index Chemicus (IC) |
